We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
67 hedge funds and large institutions have $36.1M invested in Anavex Life Sciences in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 8
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
10% more funds holding
Funds holding: 61 → 67 (+6)
0.72% less ownership
Funds ownership: 25.52% → 24.8% (-0.72%)
15% less capital invested
Capital invested by funds: $42.6M → $36.1M (-$6.56M)
82% less call options, than puts
Call options by funds: $344K | Put options by funds: $1.87M
Holders
67
Holders Change
+6
Holders Change %
+9.84%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
24
Reduced
8
Closed
5
Calls
$344K
Puts
$1.87M
Net Calls
-$1.53M
Net Calls Change
+$405K
Top Buyers
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$315K |
| 2 |
BlackRock
New York
|
+$239K |
| 3 |
Renaissance Technologies
New York
|
+$214K |
| 4 |
D.E. Shaw & Co
New York
|
+$188K |
| 5 |
Morgan Stanley
New York
|
+$120K |
Top Sellers
| 1 |
WG
Winton Group
London,
United Kingdom
|
-$291K |
| 2 |
HP
Hikari Power
Tokyo,
Japan
|
-$102K |
| 3 |
EWM
Edge Wealth Management
New York
|
-$63K |
| 4 |
VF
Virtu Financial
New York
|
-$43.3K |
| 5 |
Squarepoint
New York
|
-$40K |
